Belarus, 16 August 2024 (TDI): Holding Belpharmprom kindly invites Pakistani partners are interested in exploring the possibility of jointly implementing investment proposals. In addition, the Belarusian company is interested in the issue of localization of Pakistani medicines at the production facilities of companies belonging to the Holding Belpharmprom.
Current investment proposals (posted on the information portal «Investor Road Map» are the following:
1. Construction of a new pharmaceutical products production facility (OJSC «Ekzon»). https://map.investinbelarus.by/en/investbase/offers/38451/.
2. Creation of a center with a radiation sterilization system complex (UE «FreBor»). https://map.investinbelarus.by/en/investbase/offers/38462/.
3. Construction of a plant for the production of self-destructive disposable syringes (UE «FreBor»). https://map.investinbelarus.by/en/investbase/offers/38433/.
Belarusian organization Holding Belpharmprom is improve the management system for the pharmaceutical industry of the Republic of Belarus.
Holding includes 8 subsidiary companies: 6 pharmaceutical manufacturers, 1 scientific organization and 1 producer of medical devices.
At the same time, 20 Belarusian companies and institutes of various forms of ownership and subordination, engaged in pharmaceutical and medical activities, cooperate with the Holding on mutually beneficial terms. About 7,000 highly qualified specialists work in the companies of Holding.
The share of companies of Holding in the total volume of exports of Belarusian medicines is more than 80%, and the share of Holding in the pharmaceutical production of the Republic of Belarus is more than 60%.
Currently, 47 production sites of the companies of Holding have national Good Manufacturing Practice (GMP) certificates, 4 sites are certified for compliance with GMP PIC/S standards and 5 sites are in the process of preparatory work for obtaining GMP certificates of the European Union, 35 sites are certified for compliance with the requirements of the Good Manufacturing Practice of the Eurasian Economic Union (EAEU).
At present pharmaceutical companies of Holding have about 800 types of medicines of various pharmacotherapeutic groups in their product portfolios.
The companies’ products of the Holding are supplied to about 30 countries of the world.
Belpharmprom Holding express their readiness to organize meetings and negotiations with interested organizations, including visiting member organizations of the Holding.
